Forecast: Renin-Angiotensin System Medicine Sales in South Korea

Based on the forecasted data, sales values in billion US dollars PPP are as follows: 2024 - 2.11, 2025 - 2.15, 2026 - 2.19, 2027 - 2.23, 2028 - 2.25. The year-on-year variations in percentages are: 2025 - 1.90%, 2026 - 1.86%, 2027 - 1.83%, 2028 - 0.90%.

The Compound Annual Growth Rate (CAGR) over the next five years is 1.29%.

Key trends to observe include advancements in related medical technologies, government healthcare policies, and the socio-demographic changes in South Korea. Monitoring these factors can provide insights into potential shifts in medicine sales.

Top Countries about Cardiac Management